Profil
Debra Ainge is the founder and Chief Executive Officer & Director of Iethico Ltd., a company founded in 2021.
She is currently a Non-Executive Director at Pleco Therapeutics BV.
Previously, she worked as the Chief Operating Officer at Clinigen Ltd. Dr. Ainge holds a doctorate degree from The University of Newcastle and the University of Lausanne.
Postes actifs de Debra Ainge
| Sociétés | Poste | Début |
|---|---|---|
Pleco Therapeutics BV
Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides therapies that change the balance in the treatment of cancer | Directeur/Membre du Conseil | - |
Iethico Ltd.
Iethico Ltd. Information Technology ServicesTechnology Services Provides AI powered drug shortage solutions for medicine access | Fondateur | 11/01/2021 |
Anciens postes connus de Debra Ainge
| Sociétés | Poste | Fin |
|---|---|---|
| CLINIGEN GROUP PLC | Directeur des opérations | - |
Formation de Debra Ainge
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The University of Newcastle
The University of Newcastle Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clinigen Ltd.
Clinigen Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical services company that engages in clinical trails, regulatory affairs, distribution and commercialization of pharma companies | Commercial Services |
Iethico Ltd.
Iethico Ltd. Information Technology ServicesTechnology Services Provides AI powered drug shortage solutions for medicine access | Technology Services |
Pleco Therapeutics BV
Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides therapies that change the balance in the treatment of cancer | Commercial Services |
















